Once upon a time, electronic batch records (EBRs) were simply a means for helping pharmaceutical companies automate away the mountains of paperwork required for maintaining production batch records.
"One of the leading causes of batch release delays is a lack of visibility across teams, leading manufacturing teams to be misaligned in their priorities, while negatively affecting planning around ...
Demonstrating mRNA production capabilities suitable for late clinical and commercial scales SERAING, Belgium--(BUSINESS WIRE)--Kaneka Eurogentec, an FDA inspected contract development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback